Pharmacovigilance Market Application Development, Price Trends, Forecast by 2017 – 2024

1
Pharmacovigilance Market Trends, Opportunities,
Market Players 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Pharmacovigilance Market

• Global Market Insights, Inc. says Worldwide
  Pharmacovigilance Market having had a revenue of
  USD 3 billion in 2015, is predicted to surpass a
  revenue collection of USD 8 billion by 2024.
• The crucial need to monitor the efficiency and
  aftereffects of drugs will drive
  pharmacovigilance market.
• The field of pharmacovigilance globally
  represents the picture of drug effectiveness,
  safety, and associated risk detection.
• Most of the pharmaceutical and biotechnology
  firms are adopting these services to maintain and
  manage clinical trial data, which will favorably
  influence pharmacovigilance market share from
  in-house companies, which generated a revenue of
  USD 1.5 billion in 2015 and is likely to increase
  two-fold by 2024.
• Companies established in the developed countries
  often outsource these services, considering the
  operational cost reduction effectiveness and
  quality.

3
Continued...

• The notable business participants in
  pharmacovigilance market are Accenture,
  Boehringer Ingelheim, Covance, PAREXEL,
  Bristol-Myers Squibb, Quintiles, Cognizant
  Technology Solutions Corporation, United
  BioSource, and ICON.
• Contract outsourcing covered more than 50 of the
  revenue share of the service provider segment in
  pharmacovigilance industry in 2015 and will
  exceed a revenue collection of USD 4.8 billion by
  2024.
• Asia Pacific pharmacovigilance market having had
  a revenue of USD 835 million in 2015, will
  surpass a revenue collection of USD 2.4 billion
  by 2024.
• U.S. pharmacovigilance industry collected a
  revenue of USD 1 billion in 2015 and will exceed
  a revenue generation of USD 2.5 billion by 2024
  with an annual growth rate of 10.7 over the
  period of 2016 to 2024.
• Industry giants are engaged in strategic
  partnerships with research organizations to
  enhance the effectiveness of the product. Mergers
  acquisitions is a major growth strategy adopted
  by the market players to comply with
  competitiveness of the business.

4
U.S. Pharmacovigilance Market size, by service
provider, 2012- 2024 (USD Million)

5

Browse Full Market Research Report On
PharmacovigilanceMarket _at_ http//bit.ly/2AQAXaJ
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/853 https//www.gminsights.com/request-sample/det
ail/49
6

Table of Content
Chapter 1. Methodology and Scope 1.1.
Research Methodology 1.1.1. Initial data
exploration 1.1.2. Statistical modeling and
forecast 1.1.3. Industry insights and
validation 1.1.4. Research scope and
assumptions 1.2. Data
Sources 1.2.1. Primary Sources 1.2.2.
Secondary Sources Chapter 2. Executive
Summary 2.1. Pharmacovigilance industry 3600
synopsis, 2012 - 2024 2.1.1. Business
trends 2.1.2. End user trends 2.1.3.
Regional trends
7

Table of Content
Chapter 3. Pharmacovigilance Industry
Insights 3.1. Industry segmentation 3.2.
Industry size and forecast, 2012 - 2024 3.3.
Industry impact forces 3.3.1. Growth
drivers 3.3.1.1. Increase in adoption
rate of outsourcing services 3.3.1.2.
Increasing consumption of drugs 3.3.1.3.
Rise in adverse drug reactions (ADR) and drug
toxicity 3.3.2. Industry pitfalls
challenges 3.3.2.1. Dearth of
availability of skilled personnel 3.3.2.2.
High risk associated with data security 3.4.
Growth potential analysis 3.4.1. New business
models 3.5. Porters analysis
8

Table of Content
3.6. Regulatory Landscape 3.7.
Pharmacovigilance Reporting system 3.8.
Company market share analysis, 2015 3.8.1.
Strategy dashboard 3.9. PESTEL analysis
9
Stay In Touch Website www.gminsights.com Soci
al Media